Works matching IS 15257304 AND DT 2011 AND VI 12 AND IP 1

Results: 11

Role of Computed Tomography Fluoroscopy-Guided Cutting Needle Biopsy of Lung Lesions After Transbronchial Examination Resulting in Negative Diagnosis.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 51, doi. 10.3816/CLC.2011.n.007

By:

Matsui, Yusuke;
Hiraki, Takao;
Mimura, Hidefumi;
Gobara, Hideo;
Inoue, Daisaku;
Iishi, Tatsuhiko;
Toyooka, Shinichi;
Kanazawa, Susumu

Publication type:

Article

The Potential Application of Zoledronic Acid as Anticancer Therapy in Patients With Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 26, doi. 10.3816/CLC.2011.n.003

By:

Mahtani, Reshma;
Khan, Raza;
Jahanzeb, Mohammad

Publication type:

Article

Classification and Toxicities of Vascular Disrupting Agents.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 18, doi. 10.3816/CLC.2011.n.002

By:

Hasani, Arman;
Leighl, Natasha

Publication type:

Article

A Role for IGF-1R-Targeted Therapies in Small-Cell Lung Cancer?

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 38, doi. 10.3816/CLC.2011.n.005

By:

Gately, Kathy;
Collins, Ian;
Forde, Lydia;
Al-Alao, Bassel;
Young, Vincent;
Gerg, Michael;
Feuerhake, Friedrich;
O'Byrne, Kenneth

Publication type:

Article

Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non-Small-Cell Lung Carcinoma.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 14, doi. 10.3816/CLC.2011.n.001

By:

Gao, Wen;
Liu, Lingxiang;
Lu, Xiao;
Shu, Yongqian

Publication type:

Article

Cell Cycle Protein Cyclin Y Is Associated With Human Non-Small-Cell Lung Cancer Proliferation and Tumorigenesis.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 43, doi. 10.3816/CLC.2011.n.006

By:

Yue, Wentao;
Zhao, Xiaoting;
Zhang, Lina;
Xu, Shaofa;
Liu, Zhidong;
Ma, Li;
Jia, Wenyun;
Qian, Zhe;
Zhang, Chunyan;
Wang, Yue;
Yang, Xuehui

Publication type:

Article

Clinicopathologic Factors Affecting the Progression-Free Survival of Patients With Advanced Non-Small-Cell Lung Cancer After Gefitinib Therapy.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 56, doi. 10.3816/CLC.2011.n.008

By:

Masago, Katsuhiro;
Fujita, Shiro;
Togashi, Yosuke;
Kim, Young Hak;
Hatachi, Yukimasa;
Fukuhara, Akiko;
Nagai, Hiroki;
Sakamori, Yuichi;
Mio, Tadashi;
Mishima, Michiaki

Publication type:

Article

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 33, doi. 10.3816/CLC.2011.n.004

By:

Lara, Jr, Primo N.;
Longmate, Jeff;
Reckamp, Karen;
Gitlitz, Barbara;
Argiris, Athanassios;
Ramalingam, Suresh;
Belani, Chandra P.;
Mack, Philip C.;
Lau, Derick H. M.;
Koczywas, Mariana;
Wright, John J.;
Shepherd, Frances A.;
Leighl, Natasha;
Gandara, David R.

Publication type:

Article

Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non-Small-Cell Lung Cancer

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 70, doi. 10.3816/CLC.2011.n.010

By:

Gridelli, Cesare;
Rossi, Antonio;
Venturino, Paola;
de Marinis, Filippo

Publication type:

Article

Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 62, doi. 10.3816/CLC.2011.n.009

By:

Nagel, Sylke;
Kellner, Olaf;
Engel-Riedel, Walburga;
Guetz, Sylvia;
Schumann, Christian;
Gieseler, Frank;
Schuette, Wolfgang

Publication type:

Article

CLINICAL Lung Cancer.

Published in:

Clinical Lung Cancer, 2011, v. 12, n. 1, p. 6

By:

CIG Media Group

Publication type:

Article